July 2012


In this Issue

The Venous Challenge

As interest in venous therapies increases, so must careful study and dedicated training.


Chief Medical Editor’s Page

The Venous Challenge

By Barry T. Katzen, MD


An interventional perspective.

By Gary Siskin, MD

A neurology perspective.

By Patricia K. Coyle, MD, and Jack Burks, MD

Endovascular Options for Chronic DVT

What’s available and when to use these options.

By Mark J. Garcia, MD, FSIR

Who Should Treat Vein Disease?

Defining higher standards for vein specialists.

By Steve Elias, MD, FACS, FACPh, and Jose I. Almeida, MD, FACS, RPVI, RVT

A Closer Look at Venous Disease Stratification

Will continued reinvention result in a better wheel?

By Michael A. Vasquez, MD, FACS, RVT, and Cary Munschauer, BA

Upcoming IVC Filter Data From the American Venous Registry

The importance of data collection and how you can participate in much-needed research.

By The American Venous Forum

One Question … How Have Your Protocols for IVC Filter Placement, Monitoring, and Retrieval Changed in the Past Several Years?

With H. Bob Smouse, MD; David Trost, MD; John E. Rectenwald, MD, MS; Frank R. Arko, MD; John A. Kaufman, MD, MS; Graham Plant, MBBS, FRCR; Marvin D. Atkins, MD; Mahmood K. Razavi, MD; and Raman Uberoi, BMSCPath, MBBChir, MRCP, FRCR


Update on Antiplatelet Therapy for Peripheral Arterial Disease

Current data and guidelines for choosing the best pharmacological option for each PAD patient.

By Stephen L. Chastain, MD, and Marcus D. Stanbro, DO, FSVM

Platelet Inhibitors: Balancing Art and Science

A case-based look at platelet inhibitors and peripheral arterial intervention.

By Bruce H. Gray, DO, MSVM, FSCAI

Clopidogrel Considerations

A look at the black box warning, implications of generic options, the need for peripheral trials, and the potential for genetic testing.

By Karthikeshwar Kasirajan, MD


Applicability of Heparin-Bonded Hybrid Vascular Grafts

A case-based review in various vascular settings.

By Brant W. Ullery, MD; Ben M. Jackson, MD; Joseph Bavaria, MD; and Edward Y. Woo, MD


Sponsored by Bayer HealthCare

Current Trends in Interventional DVT Management

A roundtable discussion of the challenges faced in treating deep vein thrombosis and the benefits of endovascular therapy.

By Mark J. Garcia, MD, FSIR; Robert Lookstein, MD; Mehdi H. Shishehbor, DO, MPH; and Jeffrey Wang, MD



A preview of today’s new products

An Interview With Firas F. Mussa, MD, MS, FACS

Dr. Mussa shares his insights on the future of TEVAR for uncomplicated type B aortic dissection, percutaneous EVAR, and treatment options for CLI.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.